Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
J Am Acad Dermatol. 1997 Jan;36(1):67-71. doi: 10.1016/s0190-9622(97)70327-x.
J Am Acad Dermatol. 1997.
PMID: 8996263